MCC
ABEO icon

Money Concepts Capital’s Abeona Therapeutics ABEO Stock Holding History

Money Concepts Capital’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200
Closed -$616 – 467
2022
Q4 		$616 Buy
+200
New +$748 ﹤0.01% 2964
2022
Q2 		– Sell
-200
Closed -$2K – 1431
2022
Q1 		$2K Buy
+200
New +$1.37K ﹤0.01% 2415

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Money Concepts Capital's ABEO Position: Q1 2023 in Review

Money Concepts Capital sold out of Abeona Therapeutics (ABEO) in Q1 2023, closing a stake of 200 shares — an estimated $616 sold.

Money Concepts Capital first reported a position in ABEO in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 33 funds tracked by Wall St. Rank hold ABEO as of Q1 2023.

  • Money Concepts Capital reported no remaining Abeona Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 200 Abeona Therapeutics shares in Q1 2023, an estimated $616.
  • Money Concepts Capital first reported a position in Abeona Therapeutics in Q1 2022 and held it in 2 quarters.
  • Money Concepts Capital's Abeona Therapeutics position peaked at $2K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.